Sherwin-Williams
SHW
$299.05
-1.23%
The Sherwin-Williams Company is a global leader in the manufacture, development, distribution, and sale of paints, coatings, and related products, operating primarily in the specialty chemicals industry. It is the dominant market leader in architectural paint in the United States, distinguished by its premium brand positioning, a vast network of over 4,800 company-owned stores, and a vertically integrated business model that spans retail, consumer brands, and industrial finishes. The current investor narrative centers on the company's resilience as a dividend aristocrat, with a recent 47th consecutive annual dividend increase, juxtaposed against concerns over cyclical demand pressures in the housing and industrial markets, which are reflected in recent revenue trends and significant stock price underperformance relative to the broader market.…
SHW
Sherwin-Williams
$299.05
Related headlines
Investment Opinion: Should I buy SHW Today?
Rating & Thesis: SHW is rated a Hold. The core thesis is that while the company's fundamental quality and long-term prospects remain intact, near-term cyclical headwinds and margin pressure create an overhang that limits upside potential in the immediate future, despite a 21% implied upside to the analyst consensus target of $364.
Supporting Evidence: The Hold rating is supported by four key data points. First, valuation is in a transitional state: the forward PE of 22.62x is reasonable for a market leader but not a clear bargain given the earnings uncertainty. Second, revenue growth has decelerated to 5.64% YoY in Q4, with a sequential decline from Q3, signaling demand softness. Third, profitability is under clear pressure, with Q4 operating margin compressing 452 basis points sequentially. Fourth, while free cash flow generation of $2.65B is strong, the high debt-to-equity ratio of 3.16 adds financial risk that tempers enthusiasm.
Risks & Conditions: The two biggest risks to this thesis are: 1) a further deterioration in housing starts and industrial production, and 2) persistent inflation eroding margins beyond expectations. This Hold would upgrade to a Buy if the forward PE compresses below 20x on sustained pessimism, or if QoQ revenue and margin trends show clear stabilization for two consecutive quarters. It would downgrade to a Sell if revenue growth turns negative or if net margin falls below 7%. The stock is currently fairly valued relative to its near-term challenges but undervalued relative to its long-term market position and cash flow power.
Sign up to view all
SHW 12-Month Price Forecast
The 12-month outlook for SHW is one of cautious optimism tempered by near-term cyclical reality. The base case (50% probability) of a gradual recovery and price target in the $354-$372 range is most plausible, anchored by analyst estimates and the company's strong market position. The high short interest and 52-week low price create a favorable asymmetric setup for patient investors, but the path requires clear evidence of margin stabilization and demand inflection. The stance would upgrade to Bullish on confirmation of sequential revenue growth and operating margin expansion for two consecutive quarters. It would turn Bearish if the stock breaks decisively below the $300 support level on worsening fundamentals.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Sherwin-Williams's 12-month outlook, with a consensus price target around $388.77 and implied upside of +30.0% versus the current price.
Average Target
$388.77
9 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
9
covering this stock
Price Range
$239 - $389
Analyst target range
Analyst coverage for SHW is robust, with 9 analysts providing estimates, and the institutional sentiment leans bullish, as evidenced by recent actions from firms like Citigroup upgrading to 'Buy' and others like Mizuho and RBC maintaining 'Outperform' or equivalent ratings. The consensus recommendation is a 'Buy', with an average target price implied by the estimated EPS of $16.11 and a forward PE of 22.62x, which calculates to approximately $364, representing a potential upside of over 21% from the current price of $300.10, indicating strong analyst conviction in a recovery. The target range, derived from estimated EPS, spans from a low of $15.65 to a high of $16.45, translating to price targets of roughly $354 to $372; the high target assumes successful execution on margin initiatives and a rebound in end-market demand, while the low target likely factors in persistent inflation and a deeper housing slowdown. The relatively tight range between the low and high EPS estimates signals a fair degree of consensus on the company's near-term earnings power, reducing the uncertainty typically associated with wide target spreads.
Bulls vs Bears: SHW Investment Factors
The investment debate for SHW is a classic clash between a high-quality, market-leading business facing a severe cyclical downturn. The bear case currently has stronger near-term evidence, as reflected in the stock's 52-week low, significant margin compression, and stark underperformance. However, the bull case is supported by deep analyst conviction in a recovery, robust underlying cash generation, and a valuation that has priced in substantial pessimism. The single most important tension is the timing and magnitude of an end-market recovery in housing and industrial demand. If a rebound materializes in the next 12 months as analysts expect, the current price represents a compelling entry point. If the downturn deepens or prolongs, the stock's premium valuation and high leverage could lead to further downside.
Bullish
- Analyst Conviction & 21% Upside: Analysts maintain a strong 'Buy' consensus with an average price target of $364, implying over 21% upside from the current $300.10. This conviction is supported by a forward PE of 22.62x, which is a significant discount to the trailing PE of 31.08x, signaling expectations for an earnings recovery.
- Robust Cash Flow & Dividend Aristocrat: The company generates robust free cash flow of $2.65 billion (TTM), providing ample coverage for its operations and shareholder returns. This financial strength underpins its status as a Dividend Aristocrat, having recently declared its 47th consecutive annual dividend increase.
- Premium Gross Margins & Market Leadership: SHW maintains a premium gross margin of 48.84%, consistent with its dominant brand positioning and pricing power in the U.S. architectural paint market. This structural advantage, supported by over 4,800 company-owned stores, provides a durable competitive moat.
- Technical Support at 52-Week Low: The stock is trading at a critical technical support level, just $0.02 above its 52-week low of $300.08. This level, combined with a high short ratio of 3.56, creates a potential setup for a sharp rebound on any positive fundamental catalyst or short squeeze.
Bearish
- Severe Cyclical Downturn & Underperformance: SHW is in a pronounced cyclical downturn, with the stock down 16.97% over the past year, underperforming the S&P 500 by over 42 percentage points. Recent quarterly revenue of $5.60B shows a sequential decline from Q3's $6.36B, indicating clear demand softness in key housing and industrial markets.
- Significant Margin Compression: Profitability is under severe pressure, with Q4 net margin collapsing to 8.52% from 13.10% in Q3, and operating margin falling from 18.44% to 13.92%. This compression reflects the negative operating leverage from declining sales and persistent cost inflation.
- Elevated Leverage & Interest Rate Risk: The balance sheet carries a high debt-to-equity ratio of 3.16, which amplifies financial risk in the current environment of elevated interest rates. While cash flow is strong, this leverage constrains financial flexibility and magnifies earnings volatility.
- Premium Valuation Amidst Downturn: Despite the steep sell-off, SHW's valuation remains at a premium with a trailing PE of 31.08x and EV/EBITDA of 21.42x, which are above typical specialty chemical peers. This leaves the stock vulnerable to further multiple compression if the earnings recovery is delayed.
SHW Technical Analysis
The stock is in a pronounced downtrend, having declined 16.97% over the past year, starkly underperforming the S&P 500's 25.19% gain. With a current price of $300.10, SHW is trading at the very bottom of its 52-week range, just $0.02 above its 52-week low of $300.08, indicating it is at a critical technical support level and signaling deep investor pessimism or a potential value opportunity. Recent momentum remains decisively negative, with the stock down 8.74% over the past month and 18.65% over the past three months, accelerating the longer-term downtrend and showing no signs of a near-term reversal. The stock's beta of 1.155 indicates it is approximately 16% more volatile than the market, which has amplified its downside during this sell-off, as evidenced by its 1-month relative strength of -14.34% versus the S&P 500. Key technical levels are clearly defined, with immediate support at the 52-week low of $300.08 and resistance far above at the 52-week high of $379.65. A decisive break below the $300 support could trigger further technical selling, while any meaningful recovery would need to overcome significant overhead supply; the stock's high short ratio of 3.56 suggests a crowded bearish bet that could fuel a sharp rally on any positive catalyst.
Beta
1.16
1.16x market volatility
Max Drawdown
-20.3%
Largest decline past year
52-Week Range
$294-$380
Price range past year
Annual Return
-17.4%
Cumulative gain past year
| Period | SHW Return | S&P 500 |
|---|---|---|
| 1m | -13.5% | +3.3% |
| 3m | -18.2% | +6.9% |
| 6m | -8.8% | +12.4% |
| 1y | -17.4% | +23.4% |
| ytd | -8.8% | +7.6% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
SHW Fundamental Analysis
Revenue growth has decelerated, with Q4 2025 revenue of $5.60 billion representing a modest 5.64% year-over-year increase, a slowdown from the stronger growth rates seen in prior quarters of 2025. The quarterly trend shows revenue peaked in Q3 2025 at $6.36 billion before declining sequentially, indicating potential demand softness; segment data reveals the Paint Stores Group, at $3.13 billion, remains the largest revenue contributor, but overall growth is being tempered. Profitability remains intact but under pressure, with Q4 2025 net income of $476.8 million and a net margin of 8.52%, down from the 13.10% margin in Q3 2025. The gross margin of 48.84% is healthy and consistent with the company's premium positioning, but operating margins have compressed from 18.44% in Q3 to 13.92% in Q4, reflecting cost inflation or lower operating leverage. The balance sheet carries significant leverage, with a debt-to-equity ratio of 3.16, which elevates financial risk in a rising interest rate environment. However, the company generates robust cash flow, with trailing twelve-month free cash flow of $2.65 billion, providing ample coverage for its dividend and share repurchases; the return on equity of 55.86% is exceptionally high, albeit amplified by the substantial financial leverage.
Quarterly Revenue
$5.6B
2025-12
Revenue YoY Growth
+0.05%
YoY Comparison
Gross Margin
+0.48%
Latest Quarter
Free Cash Flow
$2.7B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is SHW Overvalued?
Given the company's positive net income, the primary valuation metric is the Price-to-Earnings (PE) ratio. SHW trades at a trailing PE of 31.08x, which is elevated, but the forward PE is notably lower at 22.62x, indicating the market expects a significant recovery in earnings over the next twelve months. Compared to sector averages, SHW's valuation presents a mixed picture: its trailing PE of 31.08x is above typical specialty chemical peers, while its Price-to-Sales ratio of 3.39x and EV/EBITDA of 21.42x also suggest a premium, justified by its market-leading position and strong brand but challenged by near-term cyclical headwinds. Historically, the current trailing PE of 31.08x sits below the stock's own 5-year peak multiples seen during the 2021-2022 period (often above 40x) but is above the lows seen during market stress, suggesting the stock is in the mid-to-lower range of its historical valuation band, pricing in some pessimism but not extreme distress.
PE
31.1x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 19x~75x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
21.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: The primary financial risk stems from SHW's elevated leverage, with a debt-to-equity ratio of 3.16, which increases interest expense sensitivity in a high-rate environment. Operational risk is evident in significant margin compression, with Q4 net income margin falling 458 basis points sequentially to 8.52%, driven by lower operating leverage on declining revenue. While free cash flow remains robust at $2.65B, a prolonged downturn could pressure this metric and challenge the company's ability to sustain its aggressive capital return program, including the recently increased dividend.
Market & Competitive Risks: The stock faces substantial market risk due to its high sensitivity to the housing cycle, as evidenced by its recent revenue deceleration to 5.64% YoY growth in Q4 from stronger prior quarters. Valuation compression is a key risk, as its trailing PE of 31.08x and EV/EBITDA of 21.42x trade at premiums to sector peers despite the cyclical headwinds, leaving room for further multiple contraction. The stock's beta of 1.155 indicates it is 16% more volatile than the market, which has amplified its recent underperformance (-18.65% over 3 months vs. S&P +8.42%) and suggests it remains vulnerable to broader market sell-offs.
Worst-Case Scenario: The worst-case scenario involves a deeper-than-expected recession in the U.S. housing market, coupled with sustained high interest rates, leading to a prolonged period of volume declines and pricing pressure. This would trigger further analyst downgrades, compress the forward PE multiple towards 18x (closer to industrial peers), and force a dividend growth pause. In this adverse scenario, the stock could realistically revisit its 52-week low of $300.08 and break below that support, potentially falling another 15-20% to the $240-$255 range, representing a total loss of 20-25% from the current price of $300.10.
FAQ
The key risks are, in order of severity: 1) Cyclical Demand Risk: Revenue is highly correlated with the housing and industrial cycles, which are currently soft (Q4 revenue declined sequentially). 2) Financial Leverage Risk: The high debt-to-equity ratio of 3.16 increases vulnerability to rising interest rates and economic stress. 3) Margin Compression Risk: Operating margins fell from 18.44% in Q3 to 13.92% in Q4; further erosion would significantly impact earnings. 4) Valuation Compression Risk: If the earnings recovery stalls, the stock's premium multiples (e.g., EV/EBITDA of 21.42x) could contract further.
The 12-month forecast centers on a base case price target of $354-$372 (50% probability), derived from the analyst consensus EPS of $16.11 and a forward PE of 22-23x. The bull case target of $372-$385 (30% probability) assumes a strong demand recovery and margin improvement, while the bear case target of $285-$310 (20% probability) factors in a deeper downturn and multiple compression. The most likely scenario is a gradual recovery, with the stock's performance heavily dependent on the trajectory of U.S. housing market data and the company's ability to stabilize profitability in the coming quarters.
SHW's valuation is in a state of transition, presenting a mixed picture. It is overvalued on a trailing basis with a PE of 31.08x, which is rich for a company facing cyclical pressure. However, it appears fairly valued to slightly undervalued on a forward-looking basis, with a forward PE of 22.62x that implies a strong earnings recovery. Compared to its own history, the current multiple is in the mid-to-lower range, suggesting some discount for the downturn. The market is currently paying a fair price for uncertainty, but not a premium for growth.
SHW presents a compelling but high-conviction opportunity for patient, long-term investors. The 21% upside to the analyst average target of $364 and the stock's position at its 52-week low suggest significant pessimism is priced in. However, it is not a low-risk buy; the high debt load (D/E of 3.16), cyclical exposure, and recent margin compression pose real near-term threats. It is a good buy for investors who believe in a 2026 housing market recovery and are willing to accept volatility, but it requires a multi-quarter holding period to realize the potential value.
SHW is unequivocally suitable for a long-term investment horizon, with a suggested minimum holding period of 3-5 years. Its cyclical nature means short-term trading is highly speculative, given its 1.155 beta and recent volatility. As a Dividend Aristocrat with 47 consecutive annual increases, it offers an attractive component for long-term income portfolios. The current downturn represents a potential long-term entry point to own a market leader, but investors must be prepared to endure near-term price fluctuations as the cycle plays out. It is not recommended for short-term traders seeking quick gains.